Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Pomalidomide and Dexamethasone | Patent Publication Number 20230295333
US 20230295333 A1Publication DateSep 21, 2023
Original Assignee
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsMing Qi
Christoph Heuck
Pamela Clemens
Zhilong Yuan
Rajesh Bandekar
Christoph Heuck
Pamela Clemens
Zhilong Yuan
Rajesh Bandekar
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.